Roots Analysis

FEBRUARY 23, 2022

Over the past few years, several companies have started offering a diverse range of genome sequencing products and services using various second and third generation sequencing technologies. Currently, close to 60 industry players are actively offering NGS kits for preparing DNA / RNA libraries. Players Engaged in the Domain.

Genetics 52

Genetics DNA RNA Reagent 52

Drug Discovery World

SEPTEMBER 28, 2022

The grants will consist of $3,000 USD (or local currency equivalent) in genomics catalog products from Beckman Coulter Life Sciences. Winners will be evaluated based on criteria that include research objective, genomic reagent request, and how the product would be used in the field of research. .

Genome 52

Genome Genomics Research Life Science 52

Roots Analysis

AUGUST 15, 2023

These expression systems utilize bio machinery harvested from the lysate of disrupted cells for the manufacturing of a wide array of macromolecular and small molecule products. Such systems provide control over the components used for the synthesis of target products making it easier to manipulate the contents according to specific needs.

Protein 52

Protein In-Vitro Production Reagent 52

The Pharma Data

JANUARY 31, 2021

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Life Science 52

Life Science Genome Genomics Reagent 52

pharmaphorum

JUNE 1, 2021

The dramatic rise in online drug sales during the COVID-19 pandemic has increased the supply of counterfeit drugs, and many companies are now considering the addition of on-dose authentication for high-risk or high-value products. Globalisation and outsourcing have led to complex supply chains for many pharmaceutical products.

Medicine 52

Medicine DNA Pharmacy Production 52

Drug Discovery World

AUGUST 19, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. These qualities make them ideal for both therapeutic applications and diagnostic reagents.

DNA 52

DNA Antibody Reagent Immune Response 52

Roots Analysis

OCTOBER 16, 2023

DNA cloning refers to the process of generating multiple copies of a particular DNA segment. DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence.

DNA 40

DNA Gene Protein In-Vitro 40

Drug Discovery World

SEPTEMBER 2, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. These qualities make them ideal for both therapeutic applications and diagnostic reagents.

Antibody 59

Antibody Production Reagent DNA 59

Drug Discovery World

AUGUST 29, 2024

Machine learning informs media exchange, plating, passaging, organoid monitoring, endpoint assays, and complex image analysis, increasing productivity and reproducibility for drug screening. According to the company, the dual-recognition, DNA-coupled technology offers high specificity, reducing the risk of wrong targets.

Drugs 59

Drugs Protein Life Science Antibody 59

The Pharma Data

JANUARY 31, 2021

NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. “As 1, 2021 00:00 UTC.

Genome 52

Genome Genomics Life Science DNA 52

Drug Discovery World

SEPTEMBER 14, 2023

If you perform all of your tasks manually, you may need to stop your initial run partway through, which means losing the reagents and samples with which you have already begun working. Automation can track logistics, such as adding reagents to a recurring order after a certain amount is used up.

Reagent 111

Reagent Life Science Scientist DNA 111

Drug Discovery World

JUNE 28, 2023

In recent years smaller, more compact products, such as liquid handlers and nucleic acid purification systems, are now commonplace and used in labs both large and small. Automation can track logistics, such as adding reagents to a recurring order after a certain amount is used up. We cannot forget about managing and analysing data.

Reagent 98

Reagent Life Science Scientist DNA 98

Drug Discovery World

OCTOBER 23, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. The post Webinar: Scaling up IVT in mRNA production appeared first on Drug Discovery World (DDW). In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented.

Production 52

Production In-Vitro Reagent DNA 52

Drug Discovery World

JANUARY 19, 2023

This paid-for advertorial by Catalent appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 One significant challenge in the manufacturing of cell and gene therapies is the production of high-quality plasmid DNA (pDNA). coli residual contaminants as well as product-related impurities. billion by 2030 (BioSpace, 11 August 2022).

DNA 52

DNA Manufacturing Gene Therapy Gene 52

Drug Discovery World

MAY 16, 2023

The deeper the understanding of product and process from a characterisation standpoint, the smoother the regulatory conversations and development pathway will be.” This will give us the opportunity to open dialogues with the regulatory body and gain invaluable experience in the marketing of our CGT product.” Manufacturability matters.

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

Pharmaceutical Technology

FEBRUARY 3, 2023

When you consider the existing challenges limiting the upstream production of viral vectors, this figure becomes even more alarming. The established method for this process is a triple transfection using three different DNA plasmids. This is already tricky at small scales but is getting close to impossible at really large scale.”

Genome 244

Genome Genomics Medicine Gene Therapy 244

Drug Discovery World

AUGUST 26, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. These qualities make them ideal for both therapeutic applications and diagnostic reagents.

Reagent 59

Reagent Antibody DNA Immune Response 59

Drug Discovery World

AUGUST 12, 2024

Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production. These qualities make them ideal for both therapeutic applications and diagnostic reagents.

Antibody 52

Antibody Reagent DNA Immune Response 52

pharmaphorum

FEBRUARY 3, 2021

However, caveats surrounding the stochastic off-target outcomes of cleaving both strands of the DNA helix to elicit a gene modification remain a source of concern. The paradigm of patient-derived autologous CAR-T cell production hinders controllable or scalable manufacturing and on-time treatment for patients.

Gene Editing 98

Gene Editing Gene DNA Engineer 98

Drug Discovery World

NOVEMBER 2, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented.

In-Vitro 52

In-Vitro Reagent DNA Production 52

Drug Discovery World

OCTOBER 16, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented.

In-Vitro 52

In-Vitro Reagent DNA Production 52

Drug Discovery World

OCTOBER 9, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented. The post Exclusive event: Scaling up in vitro transcription appeared first on Drug Discovery World (DDW).

In-Vitro 52

In-Vitro Reagent DNA Production 52

Drug Discovery World

OCTOBER 2, 2023

The effect of several variables on the IVT reaction using different size DNA templates was assessed. In this presentation, a review of the results from scaling up the IVT reaction from μg to gram scale mRNA yield will be presented.

In-Vitro 52

In-Vitro Reagent DNA Production 52

The Pharma Data

JULY 11, 2021

TAKHZYRO is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. Please consult the TAKHZYRO Summary Product Characteristics (SmPC) before prescribing.?. The reagents used in the aPTT laboratory test initiate intrinsic coagulation through the activation of plasma kallikrein in the contact system.

Allergies 52

Allergies Antibody Recombinant DNA Technology Production 52

Roots Analysis

FEBRUARY 13, 2023

It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. The production of such drug products requires skilled labor, stringent manufacturing protocols and specialized expertise.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

The Pharma Data

DECEMBER 2, 2020

Results show the protocol demonstrated a 30Gb+ yield of long DNA reads raw data of an E. The FMv8 protocol introduces a needle-aspirate-based, cell-resuspension step prior to cell lysis that boosts DNA recovery. Elsewhere around the globe: RevoluGen – U.K.-based Financial details of the agreement were not disclosed. in Mainland China.

Drugs 52

Drugs Gene Editing Genome Genomics 52

Drug Discovery World

JULY 18, 2023

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases.

DNA 98

DNA Genome Genomics RNA 98

Drug Discovery World

NOVEMBER 30, 2023

coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. It was presented by Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, titled: ‘Accelerating early discovery through HTP and high-speed antibody production’.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

OCTOBER 21, 2022

Accordingly, advances in flow cytometry technology – both in instrumentation and reagent offerings – are enabling researchers to decipher these questions, leading to new discoveries and diagnostic tools. . Reagents produced under ISO certification provide an extra level of traceability to support internal documentation and quality assurance.

Reagent 52

Reagent Antibody Drugs Protein 52

Drug Discovery World

AUGUST 12, 2024

Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way for next-generation antibody production. These qualities make them ideal for both therapeutic applications and diagnostic reagents. A Q&A session follows the webinar presentation.

DNA 52

DNA Antibody Reagent Immune Response 52

Roots Analysis

AUGUST 28, 2022

As a result, industry and non-industry stakeholders, are on the lookout for advanced platforms that can simultaneously capture the arrangement of multiple biomolecules (DNA, RNA, proteins and others) with single-cell or subcellular resolution.

Genome 52

Genome Genomics RNA Genome Project 52

Drug Discovery World

FEBRUARY 8, 2023

Svea Cheeseman , Refeyn, explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies. As demand for AAV gene therapies increases, it is becoming essential to maximise the efficiency and accuracy of AAV vector production. What makes an ideal AAV analytics tool for process development?

Gene Therapy 52

Gene Therapy Gene Antibody Production 52

Drug Discovery World

FEBRUARY 27, 2023

PerkinElmer targets screening methods End-to-end solutions provider PerkinElmer launched two new products at the show targeting both high high-throughput screening (HTS) applications and next-generation screening (NGS). You always run the risk of missed expectations when you launch a follow-on product after a game changer like the LSA.

Drugs 52

Drugs Life Science Protein Scientist 52

Drug Discovery World

JUNE 6, 2023

The only way we’re going to do that was improved diagnostic techniques.” At the meeting, Jordan says we are seeing improvements in circulating tumour DNA, circulating tumour cell diagnosis, as well as ways of detecting tumours before they are detectable through standard methodologies, such as CT scans. It’s a 1.5

Protein 52

Protein DNA RNA Research 52

Drug Discovery World

OCTOBER 14, 2022

Reducing assay volumes from about 200 µL to 1 µL ha s cut the quantities of reagents and consumables needed, while automation has replaced manual handling, so lowering running and personnel costs. . 18 However, a bottleneck in this process is analysing and confirming the identity of reaction products in a sufficiently rapid timeframe.

Drugs 52

Drugs In-Vitro Development Production 52

XTalks

OCTOBER 1, 2020

At Nurix, Dr. Hansen focuses on establishing the company’s DNA-encoded library technology platform for small molecule identification and leading the discovery organization. I think everybody is the most productive and the most successful when you are actually working for a goal that you really believe in,” she says.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

OCTOBER 14, 2020

Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery. Ltd of Japan.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52